* Embecta Corp EMBC.OQ reported quarterly adjusted
earnings of
74 cents per share for the quarter ended in June, higher than
the same quarter last year, when the company reported EPS of 26
cents. The mean expectation of five analysts for the quarter
was for earnings of 46 cents per share. Wall Street expected
results to range from 41 cents to 51 cents per share.
* Revenue fell 4.8% to $272.50 million from a year ago;
analysts
expected $267.44 million.
* Embecta Corp's reported EPS for the quarter was 25 cents.
* The company reported quarterly net income of $14.7
million.
* Embecta Corp shares had risen by 14.7% this quarter and
lost 24.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 0.3%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"
Wall Street's median 12-month price target for Embecta Corp is
$17.00
This summary was machine generated from LSEG data August 9 at
01:51 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 0.46 0.74 Beat
Mar. 31 2024 0.40 0.67 Beat
Dec. 31 2023 0.46 0.61 Beat
Sep. 30 2023 0.40 0.59 Beat